HuGE Literature Finder
Records
1
-
6
CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole. Pharmacogenomics and personalized medicine 2018 11 107-112. Denisenko Natalia P, Sychev Dmitriy A, Sizova Zhanna M, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Grishina Elena |
Modeling the cost-effectiveness of ilaprazole versus omeprazole for the treatment of newly diagnosed duodenal ulcer patients in China. Journal of medical economics 2016 Nov 19 (11): 1056-1060. Xuan J W, Song R L, Xu G X, Lu W Q, Lu Y J, Liu |
Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial. Current medical research and opinion 2012 Jan 28 (1): 101-9. Wang Ling, Zhou Liya, Hu Haitang, Lin Sanren, Xia Jiel |
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. Pharmacotherapy 2011 Mar 31 (3): 227-38. Yang Jyh-Chin, Wang Hong-Long, Chern Herng-Der, Shun Chia-Tung, Lin Bor-Ru, Lin Chun-Jung, Wang Teh-Ho |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2003 Dec 42 (6): 468-75. Lee Sang Bae, Park Sang Jong, Ryu Ji Kon, Lee Jin Kwang, Kim Hoi Jin, Bae Jin Soo, Jung Hyun Seung, Park Sil M |
[The effect of proton pump inhibitor on intragastric acidity and it relation to S-mephenytoin hydroxylase genetic polymorphism]. Zhonghua nei ke za zhi 2003 Nov 42 (11): 777-80. Wang Hong, Nie Yu-qiang, Dai Shou-jun, She Qing-zhu, Li Yu-yu |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 27, 2022
- Content source: